Inhibitor for tobacco axillary bud growth and method for inhibiting tobacco axillary bud growth
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 21, 2014
Grant Date -
Jun 20, 2013
app pub date -
Jul 26, 2011
filing date -
Sep 1, 2010
priority date (Note) -
In Force
status (Latency Note)
Importance
|
US Family Size
|
Non-US Coverage
|
|
Patent Longevity
|
Forward Citations
|
Abstract
The present invention relates to an inhibitor for tobacco axillary bud growth, the inhibitor comprising, as an active ingredient, one or more kinds of very-long chain fatty acid synthesis inhibitors such as a chloroacetamide-based herbicide, fentrazamide, cafenstrole or indanofan; an inhibitor for tobacco axillary bud growth, the inhibitor comprising the aforesaid very-long chain fatty acid synthesis inhibitor together with clorthal-dimethyl or an aliphatic alcohol having 6 to 20 carbon atoms; and a method for inhibiting tobacco axillary bud growth which comprises applying the inhibitor for tobacco axillary bud growth. The inhibitor for tobacco axillary bud growth of the present invention shows sustained drug efficacy at a low concentration, induces neither chemical injury nor disease, and can contribute to the improvement in labor productivity.
First Claim
Other Claims data not available
Family
| Country | kind | publication No. | Filing Date |
|---|---|---|---|
| WO | A1 | WO2012029446 | Jul 26, 2011 |
| JP | B2 | JP5927120 | Jul 26, 2011 |
| CN | B | CN103096709 | Jul 26, 2011 |
| BR | A2 | BR112013004956 | Jul 26, 2011 |
International Classification(s)
- 2011 Application Filing Year
- A01N Class
- 2065 Applications Filed
- 1681 Patents Issued To-Date
- 81.41 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 1 Citation Count
- A01N Class
- 23.98 % this patent is cited more than
- 11 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Apr 21, 2026 |
